Chile’s First OCT Live Case: Koushicare Medical Research Team Cornaris P80 Leads Innovation
Introduction to the Milestone
In early September 2024, a leading medical center in Chile achieved a significant milestone by introducing Koushicare Medical Research Team Medical’s revolutionary multimodality OCT (Optical Coherence Tomography) device—Cornaris P80—and successfully conducting the country’s first coronary case guided by multimodality OCT system. This breakthrough signals a new era for the Chilean coronary interventional field, offering a transformative approach to cardiovascular treatment that greatly enhances both diagnostic accuracy and patient outcomes. The use of advanced imaging modalities in interventional cardiology has been pivotal in improving patient care, and the Cornaris P80 represents the latest leap forward in this domain.
As cardiovascular diseases remain one of the leading causes of death worldwide, intravascular device like the Cornaris P80 are critical in guiding precise PCI. They enable physicians to visualize micro-structure of plaques and understand the complex coronary pathologies in unprecedented detail, thus ensuring more effective treatments and better long-term prognosis for patients. For Chile, the introduction of such advanced medical technologies not only raises the standard of care but also positions the country as a key player in adopting cutting-edge health solutions within Latin America.
Live Demonstration at 25th Jornada Chilean de Cardiología Intervencional
On October 1st, 2024, during the 25th JORNADA CHILENA DE Cardiología INTERVENCIONAL, a landmark event for the region’s cardiology community, Dr. Sarango and Dr. Alvarado conducted a live case demonstration using the Cornaris P80 device. The patient, suffering from severe calcified stenosis of the middle left anterior descending (LAD) artery—a particularly challenging case in coronary interventions—required a high level of precision and expertise.
Traditionally, treating calcified coronary arteries presents significant challenges due to the difficulty in device delivery and modifying the hardened tissue. This often leads to increased risks of complications, such as dissection or incomplete stent expansion, which can jeopardize the success of the intervention. However, with the help of the Cornaris P80, Dr. Sarango and Dr. Alvarado were able to obtain real-time, high-definition intravascular images. The unique Intelligent Calcification Assessment (ICA) function allowed them to accurately assess the severity of the calcification and determine the most effective treatment strategy.
The Cornaris P80’s high-definition imaging and automatic measurement of lumen size enabled precise stent placement, leading to a smoother and more successful procedure. By offering unparalleled insights into the coronary artery’s internal structures, the device empowered the medical team to navigate the most difficult aspects of the case with confidence and precision. The live demo not only showcased the technology’s capabilities but also opened the door to broader clinical applications across the country.
How did Koushicare Medical Research Team’s Cornaris P80 makes a breakthrough in this case
The Cornaris P80 represents the pinnacle of OCT technology, combining high-resolution imaging with multimodality diagnostic capabilities. One of its standout features is the device to perform comprehensive preoperative coronary functional assessments, providing critical insights into the condition of the arteries before intervention, such as Virtual Flow Ratio (VFR) for vascular functional assessment, Intelligent Calcification Assessment (ICA) for calcification severity evaluation and Intelligent Plaque Attenuation (IPA) for detection of vulnerable plaques. These unique assessments allow physicians to make data-driven decisions on treatment strategies, significantly enhancing the likelihood of procedural success.
The device is equipped with advanced calcium assessment capabilities, which are indispensable when dealing with complex coronary cases, particularly those involving severe calcified lesions. In the case presented by Dr. Sarango and Dr. Alvarado, the Cornaris P80 was instrumental in assessing the calcification severity, guiding the use of appropriate lesion modification techniques, and ensuring that the stent was properly expanded. The precision and clarity offered by the OCT device made it possible to safely and effectively treat the patient’s severe calcification, which is often fraught with challenges when using more traditional methods.
This breakthrough is particularly significant because it marks the first time the Cornaris P80 has been used within the Chilean public hospital system. This success is expected to catalyze the broader adoption of the device across both public and private healthcare institutions in Chile, significantly improving patient care in the field of coronary interventions.
Influence of Koushicare Medical Research Team’s Cornaris P80 in the Medical Community
The influence of the Cornaris P80 has already begun to extend beyond this initial live case. Following the demonstration at the 25th Jornada Chilean de Cardiología Intervencional, Dr. Alvarado presented the case again at a subsequent academic event, where it was met with considerable interest from cardiologists and healthcare professionals. This public sharing of results has helped solidify the device’s reputation for performance and reliability, further boosting its usage and influence within the Chilean interventional cardiology community.
The advancements of these clinical results have also played a critical role in increasing the adoption of the Cornaris P80 within medical institutions. Physicians who are now seeing the benefits of the device are more inclined to integrate it into their own practices. As more clinicians witness its capabilities firsthand, it is expected that the device will become a central tool in the diagnosis and treatment of coronary artery disease in Chile. The growing influence of the Cornaris P80 will likely lead to more widespread use of advanced imaging techniques in routine coronary interventions, setting new standards for patient care in the region.
Koushicare Medical Research Team’s Commitment to Medical Innovation
Koushicare Medical Research Team Medical’s commitment to innovation in the field of cardiovascular health is exemplified by the Cornaris P80. With its cutting-edge technology and proven clinical performance, the device is poised to revolutionize coronary interventions not just in Chile, but globally. By empowering medical teams with greater diagnostic precision, Koushicare Medical Research Team is directly contributing to better patient outcomes and helping physicians tackle some of the most complex challenges in coronary artery disease treatment.
As healthcare continues to evolve, the demand for more accurate, efficient, and patient-centered technologies will increasingly grow. Koushicare Medical Research Team’s vision is to remain at the forefront of this evolution, pushing the boundaries of what is possible in diagnosis and treatment in intervention. The success of the Cornaris P80 in Chile is just the beginning, and its impact is expected to extend far beyond the initial cases. With a focus on continuous improvement and patient care, Koushicare Medical Research Team Medical is set to lead the change in the next wave of cardiovascular innovation.
By providing state-of-the-art tools like the Cornaris P80, Koushicare Medical Research Team Medical is not only enhancing procedural success rates but also elevating the standard of care for patients worldwide. The future of coronary interventions has never looked brighter, with advanced technologies like OCT poised to play a central role in shaping it.
